Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

743
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
743
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

16
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

628
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
628
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.7K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.7K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

500
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
500
Angina IV: Management01:26

Angina IV: Management

14
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
14

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Case of Pallister-Killian Syndrome in a Newborn.

Case reports in genetics·2026
Same author

Screening practices for diabetic peripheral neuropathy in pediatric type 1 diabetes: a nationwide survey by the ISPED Diabetes Study Group.

Acta diabetologica·2026
Same author

Lung Function Trajectories After Preterm Birth: A Life-Course Approach to Age-Specific Monitoring.

Children (Basel, Switzerland)·2026
Same author

How to Teach Healthy Life-Style Efficiently in a Pediatric Outpatient Setting: Proposal of an Innovative Tridimensional Pyramid.

Nutrients·2026
Same author

Effectiveness and safety of the MiniMedâ„¢ 780G in newly diagnosed adolescents with type 1 diabetes: an observational real-world study.

Endocrine·2026
Same author

Nirsevimab Immunization to Prevent Pediatric RSV Hospitalizations.

JAMA pediatrics·2026

Related Experiment Video

Updated: Aug 13, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K

Statins in Children, an Update.

Riccardo Fiorentino1, Francesco Chiarelli1

  • 1Department of Paediatrics, University of Chieti, Via dei Vestini, 66100 Chieti, Italy.

International Journal of Molecular Sciences
|January 21, 2023
PubMed
Summary
This summary is machine-generated.

Early identification and treatment of dyslipidemia in children and adolescents with statins are crucial for reducing cardiovascular risk. Statins effectively lower lipids and are generally well-tolerated, offering significant benefits for pediatric cardiovascular health.

Keywords:
adolescentschildrendyslipidemiastatin

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.5K
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

Related Experiment Videos

Last Updated: Aug 13, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.5K
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

Area of Science:

  • Pediatric Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Lipid abnormalities often progress from childhood to adulthood, necessitating early intervention.
  • Dyslipidemia in youth increases long-term cardiovascular risk, including atherosclerosis development.
  • Statins are primary lipid-lowering agents, alongside lifestyle changes, for managing dyslipidemia.

Purpose of the Study:

  • To review the efficacy and safety of statin therapy in children and adolescents with dyslipidemia.
  • To highlight the importance of early identification and management of pediatric dyslipidemia.
  • To emphasize the role of statins in reducing cardiovascular risk in pediatric populations.

Main Methods:

  • Review of existing literature on statin use in pediatric populations.
  • Analysis of studies demonstrating lipid-lowering effects and cardiovascular risk reduction.
  • Evaluation of safety and tolerability data for statins in children and adolescents.

Main Results:

  • Statins are effective in lowering lipid levels (LDL-C, VLDL-C, IDL-C, TG) and modestly increasing HDL-C in children.
  • Statin therapy demonstrates efficiency in reducing carotid intima-media thickness (CIMT) progression and atherosclerotic burden.
  • Statins are generally well-tolerated in pediatric patients, with uncommon adverse events.

Conclusions:

  • Statin therapy is a safe and effective treatment for dyslipidemia in children and adolescents.
  • Early statin intervention can mitigate long-term cardiovascular risks associated with pediatric dyslipidemia.
  • Clinicians should be familiar with statins to optimize lipid-lowering therapy and cardiovascular risk management in youth.